Reassessing cognitive impairment prevalence in 5-FU chemotherapy: A critical methodological perspective

dc.contributor.authorWhittaker, A.L.
dc.contributor.authorSemendric, I.
dc.date.issued2025
dc.descriptionLetter to Editor
dc.description.statementofresponsibilityAlexandra L Whittaker, Ines Semendric
dc.identifier.citationCancer Research, Statistics, and Treatment, 2025; 8(1):83-84
dc.identifier.doi10.4103/crst.crst_31_25
dc.identifier.issn2590-3233
dc.identifier.issn2590-3225
dc.identifier.orcidWhittaker, A.L. [0000-0001-9011-8296]
dc.identifier.orcidSemendric, I. [0000-0002-7099-929X]
dc.identifier.urihttps://hdl.handle.net/2440/144782
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1140072
dc.rights© 2025 Cancer Research, Statistics, and Treatment | Published by Wolters Kluwer - Medknow. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
dc.source.urihttps://doi.org/10.4103/crst.crst_31_25
dc.titleReassessing cognitive impairment prevalence in 5-FU chemotherapy: A critical methodological perspective
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_144782.pdf
Size:
300.58 KB
Format:
Adobe Portable Document Format
Description:
Published version

Collections